| Literature DB >> 31727376 |
A Andama1, D Jaganath2, R Crowder3, L Asege4, M Nakaye4, D Katumba4, S Mwebe4, F Semitala5, W Worodria6, M Joloba7, S Mohanty8, A Somoskovi9, A Cattamanchi10.
Abstract
The performance of urine Xpert MTB/RIF Ultra (Xpert Ultra) for pulmonary TB diagnosis is unknown. HIV-positive and HIV-negative adults were enrolled at two health facilities in Kampala, Uganda. We compared the accuracy of urine Xpert Ultra and Determine TB-LAM in reference to sputum-based testing (positive Xpert MTB/RIF or culture), and assessed incremental yield. Urine Xpert Ultra had low sensitivity (17.2%, 95% CI 12.3-23.2) but high specificity (98.1%, 95% CI 94.4-99.6). Sensitivity reached 50.0% (95% CI 28.2-71.8) among HIV-positive patients with CD4 <100 cells/μL. Compared to Determine TB-LAM, urine Xpert Ultra was 9.4% (95% CI 3.8-14.9, P = 0.01) more sensitive, and 17.2% (95% CI 4.5-29.8, P = 0.01) more sensitive among HIV-positive patients. However, the incremental sensitivity of urine Xpert Ultra relative to sputum Xpert MTB/RIF was only 1% (95% CI -0.9 to 2.8). Urine Xpert Ultra could be an alternative for patients with advanced HIV infection unable to produce sputum.Entities:
Keywords: Diagnostics; Lipoarabinomannan; Tuberculosis; Urine; Xpert ultra
Mesh:
Substances:
Year: 2019 PMID: 31727376 PMCID: PMC6906254 DOI: 10.1016/j.diagmicrobio.2019.114892
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803